Polaryx Therapeutics

$Polaryx Therapeutics(PLYX)$ C - Offering Statement Filed: 2025-09-03 AccNo: 0001213900-25-084152 Size: 11 MB 网页链接

$Polaryx Therapeutics(PLYX)$ C-U - Progress Update Filed: 2025-10-31 AccNo: 0001213900-25-104723 Size: 10 KB 网页链接

$Polaryx Therapeutics(PLYX)$ EFFECT Notice of Effectiveness Accession Number: 9999999995-26-000339  Act: 33  Size: 1 KB 网页链接

$Polaryx Therapeutics(PLYX)$ CERT Certification by an exchange approving securities for listing Accession Number: 0001354457-26-000098  Act: 34  Size: 113 KB 网页链接

$Polaryx Therapeutics(PLYX)$ S-1/A [Amend] General form for registration of securities under the Securities Act of 1933 Accession Number: 0001213900-26-007973  Act: 33  Size: 24 MB 网页链接

$Polaryx Therapeutics(PLYX)$ S-1 - General form for registration of securities under the Securities Act of 1933 Filed: 2025-11-21 AccNo: 0001213900-25-113249 Size: 25 MB 网页链接

$Polaryx Therapeutics(PLYX)$ S-1 General form for registration of securities under the Securities Act of 1933 Accession Number: 0001213900-25-113249  Act: 33  Size: 25 MB 网页链接

$Polaryx Therapeutics(PLYX)$ S-1/A [Amend] General form for registration of securities under the Securities Act of 1933 Accession Number: 0001213900-26-004079  Act: 33  Size: 24 MB 网页链接

$Polaryx Therapeutics(PLYX)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001213900-26-009565  Size: 9 KB 网页链接

$Polaryx Therapeutics(PLYX)$ 8-A12B Registration of securities [Section 12(b)] Accession Number: 0001213900-26-008173  Act: 34  Size: 21 KB 网页链接

$Polaryx Therapeutics(PLYX)$ DRS [Cover] - Draft Registration Statement Filed: 2025-08-05 AccNo: 0001213900-25-072048 Size: 24 MB 网页链接

$Polaryx Therapeutics(PLYX)$ SCHEDULE 13D General Statement of Acquisition of Beneficial Ownership Accession Number: 0001213900-26-012759  Act: 34  Size: 21 KB 网页链接

$Polaryx Therapeutics(PLYX)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001213900-26-009566  Size: 11 KB 网页链接

$Polaryx Therapeutics(PLYX)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001213900-26-009564  Size: 11 KB 网页链接

$Polaryx Therapeutics(PLYX)$ C/A [Amend] - Offering Statement Filed: 2025-10-01 AccNo: 0001213900-25-094743 Size: 11 MB 网页链接

$Polaryx Therapeutics(PLYX)$ DRS/A [Amend] [Cover] - Draft Registration Statement Filed: 2025-09-19 AccNo: 0001213900-25-089144 Size: 24 MB 网页链接

$Polaryx Therapeutics(PLYX)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001213900-26-009567  Size: 10 KB 网页链接

$Polaryx Therapeutics(PLYX)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001213900-26-009569  Size: 9 KB 网页链接

$Polaryx Therapeutics(PLYX)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001213900-26-009563  Size: 9 KB 网页链接

$Polaryx Therapeutics(PLYX)$ 424B4 Prospectus [Rule 424(b)(4)] Accession Number: 0001213900-26-010761  Act: 33  Size: 24 MB 网页链接